Syed A. Rizvi

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Syed A. Rizvi

Caribou Biosciences, Inc. reported in an 8-K filed December 12, 2023 that Syed A. Rizvi was terminated as Chief Medical Officer, effective December 31, 2023.

“Syed Rizvi, M.D., the Chief Medical Officer of Caribou Biosciences, Inc. (the "Company"), will be leaving the Company effective December 31, 2023.”

Caribou Biosciences, Inc. Form 8-K, filed December 12, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Syed A. Rizvi's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Caribou Biosciences, Inc. (CRBU)
Proxy statement

Start not stated–2023-12-31

Company network

Recorded roles and call appearances connecting this person to public companies.

Caribou Biosciences, Inc.

CRBU

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Terminated: Chief Medical Officer Caribou Biosciences, Inc. (CRBU)
2023-12-31